Cargando…

A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma

BACKGROUND: Genetic variants associated with acute side effects of radiotherapy in nasopharyngeal carcinoma (NPC) remain largely unknown. METHODS: We performed a two-stage genome-wide association analysis including a total of 1084 patients, where 319 individuals in the discovery stage were genotyped...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yang, Xiao, Fan, Zhao, Yi, Mao, Chen-Xue, Yu, Lu-Lu, Wang, Lei-Yun, Xiao, Qi, Liu, Rong, Li, Xi, McLeod, Howard L., Hu, Bi-Wen, Huang, Yu-Ling, Lv, Qiao-Li, Xie, Xiao-Xue, Huang, Wei-Hua, Zhang, Wei, Guo, Cheng-Xian, Li, Jin-Gao, Yin, Ji-Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400233/ https://www.ncbi.nlm.nih.gov/pubmed/35999636 http://dx.doi.org/10.1186/s12943-022-01631-8

Ejemplares similares

A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma
por: Yu, Lu-Lu, et al.
Publicado: (2023)

Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy
por: Su, Sheng-Fa, et al.
Publicado: (2013)

X-chromosome association study reveals genetic susceptibility loci of nasopharyngeal carcinoma
por: Zuo, Xiao-Yu, et al.
Publicado: (2019)

Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma
por: Yu, Jingjing, et al.
Publicado: (2016)

Associations of GWAS-Identified Risk Loci with Progression, Efficacy and Toxicity of Radiotherapy of Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy
por: Li, Qinghuan, et al.
Publicado: (2021)

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma
por: Liu, Feng, et al.
Publicado: (2013)

Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
por: Chang, Hui, et al.
Publicado: (2018)

Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis
por: Wang, Chun, et al.
Publicado: (2019)

Acute Toxicities and Prognosis of Elderly Patients with Nasopharyngeal Carcinoma After Intensity-Modulated Radiotherapy: Prediction with Nomogram
por: Liang, Yu, et al.
Publicado: (2020)

Laryngeal contact granuloma after radiotherapy in patients with nasopharyngeal carcinoma: a case series
por: Mo, Ting-Ting, et al.
Publicado: (2023)

Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma
por: Peng, Gang, et al.
Publicado: (2014)

Impact of Radiotherapy Combined With Chemotherapy on Long-Term Outcomes of Patients With Recurrent Nasopharyngeal Carcinoma
por: Li, Ying, et al.
Publicado: (2023)

Potential factors associated with clinical stage of nasopharyngeal carcinoma at diagnosis: a case–control study
por: Ren, Jun-Ting, et al.
Publicado: (2017)

The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma
por: Wang, Zhihai, et al.
Publicado: (2020)

Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy
por: Zheng, YingJie, et al.
Publicado: (2015)

Concurrent Chemotherapy for T4 Classification Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
por: Cao, Cai-neng, et al.
Publicado: (2015)

Clinical and genome-wide association analysis of chemoradiation-induced hearing loss in nasopharyngeal carcinoma
por: He, Yong-Qiao, et al.
Publicado: (2023)

The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
por: Peng, Liang, et al.
Publicado: (2019)

Radiomics for Diagnosis and Radiotherapy of Nasopharyngeal Carcinoma
por: Zhang, Yu-mei, et al.
Publicado: (2022)

Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors
por: Zeng, L, et al.
Publicado: (2014)

Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis
por: Yao, Ji-Jin, et al.
Publicado: (2017)

Cone Beam CT (CBCT) Based Synthetic CT Generation Using Deep Learning Methods for Dose Calculation of Nasopharyngeal Carcinoma Radiotherapy
por: Xue, Xudong, et al.
Publicado: (2021)

Clinical Characteristics and Prognostic Factors of Early and Late Recurrence After Definitive Radiotherapy for Nasopharyngeal Carcinoma
por: Li, Feng, et al.
Publicado: (2020)

Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy
por: Zhang, Lu-Lu, et al.
Publicado: (2017)

Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma
por: Tao, Hengmin, et al.
Publicado: (2016)

Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma
por: Tao, Chang-Juan, et al.
Publicado: (2013)

Diffusion-kurtosis imaging predicts early radiotherapy response in nasopharyngeal carcinoma patients
por: Wu, Gang, et al.
Publicado: (2017)

Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma
por: Hua, Xin, et al.
Publicado: (2020)

The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma
por: Lin, Li, et al.
Publicado: (2016)

Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
por: Yi, Junlin, et al.
Publicado: (2014)

Prognostic Significance of Tumor Volume in Locally Recurrent Nasopharyngeal Carcinoma Treated with Salvage Intensity-Modulated Radiotherapy
por: Xiao, WeiWei, et al.
Publicado: (2015)

Association Analysis of Single Nucleotide Polymorphisms at Five Loci: Comparison between Atopic Dermatitis and Asthma in the Chinese Han Population
por: Tang, Hua-Yang, et al.
Publicado: (2012)

Prospective matched study on comparison of volumetric-modulated arc therapy and intensity-modulated radiotherapy for nasopharyngeal carcinoma: dosimetry, delivery efficiency and outcomes
por: Chen, Bin-Bin, et al.
Publicado: (2018)

Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Li, Jia-xin, et al.
Publicado: (2014)

Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia
por: Zhang, Qing, et al.
Publicado: (2018)

Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity‐modulated radiotherapy
por: Xiao, Xiao‐Tang, et al.
Publicado: (2022)

Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma
por: OuYang, Pu-Yun, et al.
Publicado: (2016)

Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2018)

Effects of intensity-modulated radiotherapy and chemoradiotherapy on attention in patients with nasopharyngeal cancer
por: Wei, Qing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_thcq692qf25d90c4om78ov0kn9